Chirayu Rana, a 35-year-old principal at Bregal Sagemount, has filed a sexual harassment lawsuit against JPMorgan executive Lorna Hajdini. This legal action comes shortly after Rana left his position, alleging serious misconduct including drugging and coercion. However, an internal investigation conducted by JPMorgan has found no evidence to support these claims.
Rana’s allegations are striking—he claims he was drugged with Viagra and kept as a ‘sex slave.’ Following the internal review, Hajdini’s allies have publicly described Rana’s allegations as baseless and a complete fabrication. A spokesperson for JPMorgan stated, “We don’t believe there’s any merit to these claims.”
Interestingly, both individuals worked under different managers at JPMorgan, raising questions about the veracity of Rana’s accusations. The timeline of events is crucial here: Rana joined JPMorgan in 2024 and filed an internal complaint in 2025 before leaving Bregal Sagemount on April 2, 2026.
Key facts surrounding the case:
- Rana has previously held roles at major firms like Morgan Stanley and Credit Suisse.
- His lawsuit was initially filed under the pseudonym John Doe.
- Rana sought millions in a payoff to leave JPMorgan.
Hajdini categorically denies all allegations against her. Her ally stated that Rana has tarnished her reputation with what they deem a complete fabrication. The implications of this case extend beyond individual reputations; they touch on broader issues within the financial services industry regarding workplace conduct and accountability.
The next steps remain uncertain. Although Rana’s lawsuit is still reportable due to absolute privilege against defamation claims in the U.S., the lack of substantiating evidence from the internal investigation could significantly impact its trajectory.
